Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 15,746 Shares
Insider Sale at Mineralys Therapeutics Inc (MLYS): CFO and Secretary Adam Levy Sells Shares
Mineralys Therapeutics Price Target Announced at $30.00/Share by HC Wainwright & Co.
Mineralys Therapeutics Analyst Ratings
H.C. Wainwright Initiates Mineralys Therapeutics(MLYS.US) With Buy Rating, Announces Target Price $30
Buy Rating Justified by Mineralys Therapeutics' Promising Hypertension and CKD Drug Lorundrostat
Express News | Mineralys Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating
Insider Sale: CEO Jon Congleton Sells Shares of Mineralys Therapeutics Inc (MLYS)
Mineralys Therapeutics(MLYS.US) Officer Sells US$592.02K in Common Stock
Mineralys Therapeutics Insider Sold Shares Worth $592,022, According to a Recent SEC Filing
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 175.24K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 20, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 14,940 shares of its common stock on Jun 20, with a total market value of approximately $175.24K
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 199.07K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 18, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 16,607 shares of its common stock on Jun 18, with a total market value of approximately $199.07K
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 217.71K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 17,766 shares of its common stock on Jun 17, with a total market value of approximately $217.71K
Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 72,797 Shares
Mineralys Therapeutics(MLYS.US) Officer Sells US$924.2K in Common Stock
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 203.16K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 16,229 shares of its common stock on Jun 14, with a total market value of approximately $203.16K
Express News | Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.d. to Its Board of Directors
Insider Sale: CFO and Secretary Adam Levy Sells 96,815 Shares of Mineralys Therapeutics Inc (MLYS)
Mineralys Therapeutics(MLYS.US) Officer Sells US$1.25 Million in Common Stock
Mineralys Therapeutics Insider Sold Shares Worth $1,252,718, According to a Recent SEC Filing